Lab to Lives
A simple question started this show: How do we medicine from the lab to making a difference in people's lives as quickly as possible?
The answers are complex. Actual solutions are hard to come by. We want to distill ideas until we see actual impact in the industry.
Our three hosts all have backgrounds in life sciences and in improv comedy. Together, with their guests, they're on a mission to have conversations that can have an impact. And have some fun along the way.
Lab to Lives
Ulla Sofie Lønberg and Helle Hartnack on Bias: How behavioral trials can transform access to treatment
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
“It is always fun to have some data that makes you go Wow! I didn’t know this!”
We speak to Ulla Sofie Lønberg and Helle Hartnack about whether men are risk takers and women reluctant to experiment with health technology, and if the only difference between the male and female physiology really is the ability to bear children.
We discuss the findings in a recent registry study about gender imbalance in the use of device-aided therapies. Unconscious bias may be at play for both patients, carers and physicians when selecting treatment, but also the roles that men and women typically play in society.
We speak about how tailoring communication might make a difference, but also the need for behavioral clinical research. Adding the behavioral element to clinical research may just be the missing link in true patient centricity.
We also speak about how mapping the non-patient journey may help understand the biases that exist in the system and how daring to differentiate your communication to patient groups may make it easier for the patients to make decisions about treatment.
“I found that when we discussed these findings with people, we tend to get the same kind of comments. Either that men are risk-takers or men are tech-oriented and women are not. But what we discussed in this publication is that there’s actually very little data to support this notion. And if it is true that men are risk takers and women are not, should we just accept that?”
- Ulla Sofie Lønberg
Notes
- Guest Ulla Sofie Lønberg : https://www.linkedin.com/in/mdullasofielonberg/
- Guest Helle Hartnack: https://www.linkedin.com/in/helle-hartnack-0345352/
- Publication we speak about: Henriksen T, Dalhoff KP, Hansen HE, Brenneche AW, Lønberg US, Danielsen EH. Access and Use of Device-Aided Therapies for Parkinson’s Disease in Denmark. Mov Disord Clin Pract. 2020 Jul 2;7(6):656-663. doi: 10.1002/mdc3.12988.
- Invisible women: https://www.goodreads.com/book/show/41104077-invisible-women
- Device-aided therapies and Parkinson’s disease
Visit Labtolives.com
Do you want to try the quiz from this episode? Find the link on our LinkedIn profile: https://www.linkedin.com/company/labtolives/
Would you like to join the show as a guest or collaborator? Find out how on our website: https://www.labtolives.com/
________
Reach out to Ivanna Rosendal
Join the conversation on our LinkedIn page
Visit www.labtolives.com
Hosts
Alexander Booth aka the MedTech Guy
Dimitri Borisevich aka the start-up Guy
Ivanna Rosendal aka the R&D pharma Gal
.png)
